{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:53:40Z","timestamp":1790970820494,"version":"4.1.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"40","license":[{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10,2]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Although drug-coated balloons (DCBs) are increasingly used in acute coronary syndrome (ACS), evidence regarding mid-term clinical outcomes after DCB angioplasty remains limited. Real-world data evaluating whether intravascular ultrasound (IVUS)-guided lesion preparation is associated with improved outcomes compared with angiography-guided intervention are scarce, particularly in patients with complex coronary lesions. This study compares clinical outcomes associated with IVUS versus coronary angiography (CAG) guidance for DCB angioplasty in patients with ACS, focusing on major adverse cardiovascular events (MACE) and net adverse clinical events (NACE) within the prespecified 24-month observation window. This retrospective study included 229 patients with ACS treated with DCB angioplasty between October 2017 and June 2025. Patients were categorized into IVUS-guided (n\u2005=\u2005122) and CAG-guided (n\u2005=\u2005107) groups according to the imaging strategy used during the procedure. Inverse probability of treatment weighting (IPTW) was applied to adjust for baseline confounders. The primary endpoints were MACE and NACE occurring within the prespecified 24-month observation window after DCB angioplasty. Secondary outcomes included individual clinical events, procedural characteristics, length of stay, and biochemical parameters assessed at predefined follow-up time points. After IPTW adjustment, baseline characteristics were balanced between groups. Procedural parameters, including DCB diameter, number of DCBs deployed, and bailout stenting rate, were comparable (all\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&gt;\u2005.05). Within the prespecified 24-month observation window, MACE occurred less frequently in the IVUS group than in the CAG group (8.2% vs 17.8%; IPTW\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.038). Major bleeding was also lower in the IVUS group (1.6% vs 11.2%; IPTW\n                      <jats:italic toggle=\"yes\">P\u2005<\/jats:italic>\n                      =\u2005.015), contributing to a lower incidence of NACE (9.8% vs 26.2%; IPTW\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.001). IVUS guidance was additionally associated with a shorter hospital stay (4.2 vs 5.8 days;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.001), while biochemical parameters remained comparable during follow-up. In patients with ACS treated with DCB, IVUS\u2011guided angioplasty was associated with significantly lower MACE and improved NACE outcomes during follow-up compared with angiography\u2011guided therapy alone. This benefit was largely attributable to an improved safety profile (e.g., fewer bleeding events). The associations remained consistent across subgroups, suggesting that IVUS\u2011guided lesion preparation may offer clinical value in this population and warrants further investigation.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050803","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:00:55Z","timestamp":1790967655000},"page":"e50803","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Clinical outcomes of intravascular ultrasound-guided drug-coated balloon angioplasty for acute coronary syndrome"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-1723-6217","authenticated-orcid":false,"given":"Wei","family":"Wen","sequence":"first","affiliation":[{"name":"Shantou University Medical College, Shantou, Guangdong, China"},{"name":"Department of Cardiology, The First Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongdong","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6942-2873","authenticated-orcid":false,"given":"Haibo","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261002","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.jcin.2020.02.043","article-title":"Drug-coated balloons for coronary artery disease: third report of the international DCB consensus group.","volume":"13","author":"Jeger","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"R2-20261002","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.carrev.2021.03.008","article-title":"Outcomes with drug-coated balloons vs. drug-eluting stents in small-vessel coronary artery disease.","volume":"35","author":"Megaly","year":"2022","journal-title":"Cardiovasc Revasc Med"},{"key":"R3-20261002","doi-asserted-by":"crossref","first-page":"e038071","DOI":"10.1161\/JAHA.124.038071","article-title":"Successful or uncomplicated use of drug-coated balloon versus drug-eluting stent strategies for de novo culprit lesions in acute coronary syndromes: insights from a nationwide registry in Japan.","volume":"14","author":"Takahashi","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"R4-20261002","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jacc.2025.10.027","article-title":"Drug-coated balloon angioplasty vs up-front stenting for de novo CAD: 3-year follow-up of REC-CAGEFREE I trial.","volume":"87","author":"Tao","year":"2026","journal-title":"J Am Coll Cardiol"},{"key":"R5-20261002","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1093\/eurheartj\/ehz332","article-title":"Clinical use of intracoronary imaging. part 2: acute coronary syndromes, ambiguous coronary angiography findings, and guiding interventional decision-making: an expert consensus document of the European Association of percutaneous cardiovascular interventions.","volume":"40","author":"Johnson","year":"2019","journal-title":"Eur Heart J"},{"key":"R6-20261002","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1093\/eurheartj\/ehy285","article-title":"Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of percutaneous cardiovascular interventions.","volume":"39","author":"R\u00e4ber","year":"2018","journal-title":"Eur Heart J"},{"key":"R7-20261002","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jacc.2022.11.045","article-title":"Intravascular imaging during percutaneous coronary intervention: JACC state-of-the-art review.","volume":"81","author":"Truesdell","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"R8-20261002","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC Guidelines for the management of acute coronary syndromes.","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"R9-20261002","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Fourth universal definition of myocardial infarction (2018).","volume":"72","author":"Thygesen","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R10-20261002","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1161\/CIRCULATIONAHA.117.029289","article-title":"Standardized end point definitions for coronary intervention trials: the academic research consortium-2 consensus document.","volume":"137","author":"Garcia-Garcia","year":"2018","journal-title":"Circulation"},{"key":"R11-20261002","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium.","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"R12-20261002","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies.","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"R13-20261002","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/sim.6607","article-title":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies.","volume":"34","author":"Austin","year":"2015","journal-title":"Stat Med"},{"key":"R14-20261002","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1093\/eurheartj\/ehae621","article-title":"Is intravascular ultrasound needed to optimize drug-coated balloon angioplasty results?","volume":"45","author":"Alfonso","year":"2024","journal-title":"Eur Heart J"},{"key":"R15-20261002","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1177\/00033197231198674","article-title":"Comparison of long-term outcomes between intravascular ultrasound-, optical coherence tomography- and angiography-guided stent implantation: a meta-analysis.","volume":"75","author":"\u015eaylik","year":"2024","journal-title":"Angiology"},{"key":"R16-20261002","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1056\/NEJMoa2601521","article-title":"Intravascular ultrasound-guided or angiography-guided complex high-risk PCI.","volume":"394","author":"Diletti","year":"2026","journal-title":"N Engl J Med"},{"key":"R17-20261002","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa2600440","article-title":"IVUS-guided versus angiography-guided PCI in unprotected left main coronary disease.","volume":"394","author":"Testa","year":"2026","journal-title":"N Engl J Med"},{"key":"R18-20261002","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1056\/NEJMoa2216607","article-title":"Intravascular imaging-guided or angiography-guided complex PCI.","volume":"388","author":"Lee","year":"2023","journal-title":"N Engl J Med"},{"key":"R19-20261002","doi-asserted-by":"crossref","first-page":"e010230","DOI":"10.1161\/CIRCOUTCOMES.123.010230","article-title":"Cost-effectiveness of intravascular imaging-guided complex PCI: prespecified analysis of RENOVATE-COMPLEX-PCI trial.","volume":"17","author":"Hong","year":"2024","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"R20-20261002","first-page":"532","article-title":"Long term clinical outcome of sirolimus drug coated balloons in large coronary vessels.","volume":"103","author":"Sciahbasi","year":"2024","journal-title":"Catheter Cardiovasc Interv"},{"key":"R21-20261002","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0140-6736(21)00249-X","article-title":"Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study.","volume":"397","author":"Erlinge","year":"2021","journal-title":"Lancet"},{"key":"R22-20261002","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/S0140-6736(19)31794-5","article-title":"Identification of patients and plaques vulnerable to future coronary events with near-infrared spectroscopy intravascular ultrasound imaging: a prospective, cohort study.","volume":"394","author":"Waksman","year":"2019","journal-title":"Lancet"},{"key":"R23-20261002","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1056\/NEJMoa2305861","article-title":"Optical coherence tomography-guided versus angiography-guided PCI.","volume":"389","author":"Ali","year":"2023","journal-title":"N Engl J Med"},{"key":"R24-20261002","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1093\/ehjqcco\/qcad073","article-title":"Cost-effectiveness of intravascular ultrasound-guided percutaneous intervention in patients with acute coronary syndromes: a UK perspective.","volume":"10","author":"Sharp","year":"2024","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"R25-20261002","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines.","volume":"79","author":"Lawton","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"R26-20261002","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s00392-020-01734-6","article-title":"Long-term safety of paclitaxel drug-coated balloon-only angioplasty for de novo coronary artery disease: the SPARTAN DCB study.","volume":"110","author":"Merinopoulos","year":"2021","journal-title":"Clin Res Cardiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050803","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:00:59Z","timestamp":1790967659000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050803"}},"subtitle":["A single-center retrospective cohort study"],"short-title":[],"issued":{"date-parts":[[2026,10,2]]},"references-count":26,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050803","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,2]]},"assertion":[{"value":"2026-05-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}